Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum
Thieme. All rights reserved..
Oxystelma esculentum has been used as a folk medicine to treat jaundice, throat infections, and skin problems. In the current study, the bone fracture-healing properties of a flavonoid-enriched fraction (Oxy50-60F) of O. esculentum were investigated in Swiss mice using a drill-hole injury model. Oxy50-60F (1 mg/kg/day, 5 mg/kg/day, and 10 mg/kg/day) was administered orally (from the next day) after a 0.6 mm drill-hole injury in mice femur mid-diaphysis for 7 days and 14 days. Parathyroid hormone (40 µg/kg; 5 times/week) was given subcutaneously as the positive control. Confocal imaging for bone regeneration, micro-architecture of femur bones, ex vivo mineralization, hematoxyline and eosin staining, measurement of reactive oxygen species, and gene expression of osteogenic and anti-inflammatory genes were studied. Quercetin, kaempferol, and isorhamnetin glycosides were identified in the active fraction using mass spectrometry techniques. Our results confirm that Oxy50-60F treatment promotes fracture healing and callus formation at drill-hole sites and stimulates osteogenic and anti-inflammatory genes. Oxy50-60F administration to fractured mice exhibited significantly better micro-CT parameters in a dose-dependent manner and promoted nodule mineralization at days 7 and 14 post-injury. Oxy50-60F also prevents ROS generation by increasing expression of the SOD2 enzyme. Overall, this study reveals that Oxy50-60F has bone regeneration potential in a cortical bone defect model, which supports its use in delayed-union and non-union fracture cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
---|---|
Enthalten in: |
Planta medica - 90(2024), 2 vom: 19. Jan., Seite 96-110 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rawat, Priyanka [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 22.01.2024 Date Revised 22.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/a-2192-2138 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363390820 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363390820 | ||
003 | DE-627 | ||
005 | 20240122231913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/a-2192-2138 |2 doi | |
028 | 5 | 2 | |a pubmed24n1267.xml |
035 | |a (DE-627)NLM363390820 | ||
035 | |a (NLM)37846499 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rawat, Priyanka |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.01.2024 | ||
500 | |a Date Revised 22.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a Oxystelma esculentum has been used as a folk medicine to treat jaundice, throat infections, and skin problems. In the current study, the bone fracture-healing properties of a flavonoid-enriched fraction (Oxy50-60F) of O. esculentum were investigated in Swiss mice using a drill-hole injury model. Oxy50-60F (1 mg/kg/day, 5 mg/kg/day, and 10 mg/kg/day) was administered orally (from the next day) after a 0.6 mm drill-hole injury in mice femur mid-diaphysis for 7 days and 14 days. Parathyroid hormone (40 µg/kg; 5 times/week) was given subcutaneously as the positive control. Confocal imaging for bone regeneration, micro-architecture of femur bones, ex vivo mineralization, hematoxyline and eosin staining, measurement of reactive oxygen species, and gene expression of osteogenic and anti-inflammatory genes were studied. Quercetin, kaempferol, and isorhamnetin glycosides were identified in the active fraction using mass spectrometry techniques. Our results confirm that Oxy50-60F treatment promotes fracture healing and callus formation at drill-hole sites and stimulates osteogenic and anti-inflammatory genes. Oxy50-60F administration to fractured mice exhibited significantly better micro-CT parameters in a dose-dependent manner and promoted nodule mineralization at days 7 and 14 post-injury. Oxy50-60F also prevents ROS generation by increasing expression of the SOD2 enzyme. Overall, this study reveals that Oxy50-60F has bone regeneration potential in a cortical bone defect model, which supports its use in delayed-union and non-union fracture cases | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Flavonoids |2 NLM | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
700 | 1 | |a Sharma, Kriti |e verfasserin |4 aut | |
700 | 1 | |a Khanka, Sonu |e verfasserin |4 aut | |
700 | 1 | |a Singh, Yatendra |e verfasserin |4 aut | |
700 | 1 | |a Prakash, Ravi |e verfasserin |4 aut | |
700 | 1 | |a Rais, Nisha |e verfasserin |4 aut | |
700 | 1 | |a Maurya, Arvind Kumar |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Ritika |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Dipak K |e verfasserin |4 aut | |
700 | 1 | |a Singh, Divya |e verfasserin |4 aut | |
700 | 1 | |a Kanojiya, Sanjeev |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Planta medica |d 1961 |g 90(2024), 2 vom: 19. Jan., Seite 96-110 |w (DE-627)NLM000844535 |x 1439-0221 |7 nnns |
773 | 1 | 8 | |g volume:90 |g year:2024 |g number:2 |g day:19 |g month:01 |g pages:96-110 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-2192-2138 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 90 |j 2024 |e 2 |b 19 |c 01 |h 96-110 |